The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Heart failure - Primary Care

Friday, 23 February 2018
Stories in this Evidence in Practice include: Health survey for England, 2016: The good and the bad news Healthy lifestyle changes have a long-term benefit for type 2 diabetes prevention Weight loss diets reduce the risk of premature death for people with obesity Very low calorie diet can achieve a remission of Type 2 Diabetes Dash diet plus sodium reduction lowers systolic blood pressure Long-term follow-up underscores benefits of lowering LDL-C in CVD primary prevention Blood pressure self-monitoring is more effective with professional support AF and other chronic conditions = higher risk of death Clinical trials underestimate the real-world impact of Atherosclerotic CVD The burden of heart failure continues to rise in the UK
Thursday, 02 February 2017
A practical down-to-earth manual on the whole range of long-term conditions has been written for UK general practice nurses by experts in their field. The book provides a quick way for new practice nurses to learn the basics about long-term conditions and will also be useful to the wider primary healthcare team.
Category: Have You Heard
Monday, 17 July 2017
A new series of 40 films on heart failure have been released by the Sound Doctor, a leading provider of health-related film and audio content for patients. The films are released in partnership with Guy’s and St Thomas’ NHS Foundation Trust and Kings College Hospital NHS Trust, and have been produced with input from the British Heart Foundation (BHF).
Category: Have You Heard
Monday, 25 February 2019
The updated Chronic Heart Failure guideline from the National Institute for Health and Care Excellence was published in September. This article covers the key recommendations relevant to primary care.
Category: Editorial
Friday, 30 October 2015
Heart failure (HF) is an important cause of morbidity, mortality and misery for patients. However, there are many ways to improve and extend the lives of people with HF, if clinicians are familiar with and apply the numerous traditional, less mainstream and more innovative evidence-based treatment options. This article reviews current best practice in the management of chronic HF and of acute decompensated HF, and considers recent insights, controversies and innovations in this important, fast moving field.
Category: Editorial
Saturday, 09 September 2017
New research has revealed that medication is so effective in reducing the risk of sudden death in patients with heart failure with reduced ejection fraction that the overall benefit of implantable cardioverter-defibrillators (ICDs) is uncertain. The research analysed individual patient data from 12 clinical trials conducted between 1995 and 2014 including 40,000 patients.
Friday, 28 October 2016
Commissioning is not so different from seeing patients. As a GP you listen, examine, draw up a diagnosis and plan treatment. In commissioning, the community served by the clinical commissioning group (CCG) is the ‘patient’. When considering the introduction of a new treatment for heart failure (HF) such as sacubitril/valsartan (Entresto), we must consider not only its acquisition costs but also its potential benefits in improving patients' symptoms and reducing expensive hospital admissions.
Category: Editorial
Monday, 21 November 2016
Sacubitril/valsartan (Entresto), the first angiotensin receptor-neprilysin inhibitor (ARNI), is a recently licensed medication that has been shown to improve outcomes for patients with symptomatic chronic HF with reduced ejection fraction (HF-REF) compared with current gold-standard treatment with an ACE inhibitor. This article describes the pharmacist’s role in supporting patients receiving sacubitril/valsartan.
Category: Editorial
Monday, 21 November 2016
Many patients with heart failure rely on practice nurses to monitor their care. A multidisciplinary team (MDT) integrated community approach has been endorsed by NICE guidelines when delivering HF care. This article provides practice nurses with the information they need to understand the condition, current treatment guidelines, and the new treatment – sacubitril/valsartan, the first-in-class angiotensin receptor-neprilysin inhibitor.
Category: Editorial
Page 3 of 5

Article search and filter